Cargando…

The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial

BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosadegh, Mehrdad, Khalkhali, Aref, Erfani, Yousef, Nezamdoost, Manije
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482870/
https://www.ncbi.nlm.nih.gov/pubmed/36165862
http://dx.doi.org/10.1016/j.micpath.2022.105792
_version_ 1784791548781658112
author Mosadegh, Mehrdad
Khalkhali, Aref
Erfani, Yousef
Nezamdoost, Manije
author_facet Mosadegh, Mehrdad
Khalkhali, Aref
Erfani, Yousef
Nezamdoost, Manije
author_sort Mosadegh, Mehrdad
collection PubMed
description BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study was a randomized, comparative, parallel two-arm and single-blind clinical trial study performed in Tehran, Iran. In total, 70 patients with COVID-19 were included in the present study and assigned to two groups including 1) intervention group (n = 35) and 2) control group (n = 35). All patients included in the intervention group received 4.5 gr daily rate of NBS superfood, three times the daily rate of 1.5 gr for 14 days. In contrast, patients included in the control group received a placebo three times a day for 14 days. The measurement of laboratory parameters including CRP, ESR, D-Dimer, LDH, CPK, SGOT, SGPT, ALP, FBG, WBC count, PLT, and lymphocyte count was performed using standard kits and methods. Moreover, all serum samples were tested to determine the levels of IL-6 and TNF-ɑ using specific commercially available ELISA kits according to the instructions of the manufacturer. RESULTS: A significant decrease in the mean serum level of several variables including CRP (p < 0.001), ESR (p < 0.001), D- Dimer (p = 0.001), LDH (p < 0.001), SGOT (p = 0.002), SGPT (p = 0.019), ALP (p < 0.001), WBC count (p < 0.001), body temperature (p = 0.013), IL-6 (p < 0.001), and TNF-α (p < 0.001) was seen 14 days after intervention from baseline in the intervention group than control group. In contrast, in the intervention group, the significant increase from baseline of lymphocyte percentage (p < 0.001) and oxygen saturation (p < 0.001) was seen 14 days after receiving NBS superfood than the control group. CONCLUSION: Results showed that the use of NBS superfood had various beneficial effects on COVID-19 disease severity. These results suggest that NBS superfood can be used as an effective natural supplement in the treatment process of COVID-19 disease.
format Online
Article
Text
id pubmed-9482870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94828702022-09-19 The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial Mosadegh, Mehrdad Khalkhali, Aref Erfani, Yousef Nezamdoost, Manije Microb Pathog Article BACKGROUND: Nutrition Bio-shield Superfood (NBS) is an organic and viable herbal supplement that could improve the function of the immune system. The present study aims to determine the effect of NBS on disease severity and laboratory biomarkers in patients with COVID-19. METHODS: This current study was a randomized, comparative, parallel two-arm and single-blind clinical trial study performed in Tehran, Iran. In total, 70 patients with COVID-19 were included in the present study and assigned to two groups including 1) intervention group (n = 35) and 2) control group (n = 35). All patients included in the intervention group received 4.5 gr daily rate of NBS superfood, three times the daily rate of 1.5 gr for 14 days. In contrast, patients included in the control group received a placebo three times a day for 14 days. The measurement of laboratory parameters including CRP, ESR, D-Dimer, LDH, CPK, SGOT, SGPT, ALP, FBG, WBC count, PLT, and lymphocyte count was performed using standard kits and methods. Moreover, all serum samples were tested to determine the levels of IL-6 and TNF-ɑ using specific commercially available ELISA kits according to the instructions of the manufacturer. RESULTS: A significant decrease in the mean serum level of several variables including CRP (p < 0.001), ESR (p < 0.001), D- Dimer (p = 0.001), LDH (p < 0.001), SGOT (p = 0.002), SGPT (p = 0.019), ALP (p < 0.001), WBC count (p < 0.001), body temperature (p = 0.013), IL-6 (p < 0.001), and TNF-α (p < 0.001) was seen 14 days after intervention from baseline in the intervention group than control group. In contrast, in the intervention group, the significant increase from baseline of lymphocyte percentage (p < 0.001) and oxygen saturation (p < 0.001) was seen 14 days after receiving NBS superfood than the control group. CONCLUSION: Results showed that the use of NBS superfood had various beneficial effects on COVID-19 disease severity. These results suggest that NBS superfood can be used as an effective natural supplement in the treatment process of COVID-19 disease. Elsevier Ltd. 2022-11 2022-09-19 /pmc/articles/PMC9482870/ /pubmed/36165862 http://dx.doi.org/10.1016/j.micpath.2022.105792 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mosadegh, Mehrdad
Khalkhali, Aref
Erfani, Yousef
Nezamdoost, Manije
The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title_full The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title_fullStr The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title_full_unstemmed The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title_short The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial
title_sort effect of nutrition bio-shield superfood (nbs) on disease severity and laboratory biomarkers in patients with covid-19: a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482870/
https://www.ncbi.nlm.nih.gov/pubmed/36165862
http://dx.doi.org/10.1016/j.micpath.2022.105792
work_keys_str_mv AT mosadeghmehrdad theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT khalkhaliaref theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT erfaniyousef theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT nezamdoostmanije theeffectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT mosadeghmehrdad effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT khalkhaliaref effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT erfaniyousef effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial
AT nezamdoostmanije effectofnutritionbioshieldsuperfoodnbsondiseaseseverityandlaboratorybiomarkersinpatientswithcovid19arandomizedclinicaltrial